Onconetix, Inc. Liabilities Assumed
Onconetix, Inc. (ONCO) reported Liabilities Assumed of $157.72 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2026-03-13
- Onconetix, Inc. liabilities assumed for the quarter ending 2024-12-31 was $0.00.
- Onconetix, Inc. liabilities assumed for the quarter ending 2023-12-31 was $0.00.
- Onconetix, Inc. liabilities assumed for fiscal 2024 was $157.72K, a 510.44% increase from fiscal 2023.
- Onconetix, Inc. liabilities assumed for fiscal 2023 was $25.84K.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $157.72K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $157.72K 10-Q · filed 2025-11-13 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $25.84K 10-K · filed 2025-06-02 | |
| 2023-09-30 | $25.84K 10-Q · filed 2024-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |